Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth

肿瘤相关巨噬细胞分泌多效蛋白,促进胶质母细胞瘤干细胞中的PTPRZ1信号通路,从而促进肿瘤生长。

阅读:2
作者:Yu Shi,Yi-Fang Ping,Wenchao Zhou,Zhi-Cheng He,Cong Chen ,Bai-Shi-Jiao Bian,Lin Zhang,Lu Chen,Xun Lan,Xian-Chao Zhang,Kai Zhou,Qing Liu,Hua Long,Ti-Wei Fu,Xiao-Ning Zhang,Mian-Fu Cao,Zhi Huang,Xiaoguang Fang,Xiuxing Wang,Hua Feng,Xiao-Hong Yao,Shi-Cang Yu,You-Hong Cui,Xia Zhang,Jeremy N Rich,Shideng Bao,Xiu-Wu Bian

Abstract

Intense infiltration of tumour-associated macrophages (TAMs) facilitates malignant growth of glioblastoma (GBM), but the underlying mechanisms remain undefined. Herein, we report that TAMs secrete abundant pleiotrophin (PTN) to stimulate glioma stem cells (GSCs) through its receptor PTPRZ1 thus promoting GBM malignant growth through PTN-PTPRZ1 paracrine signalling. PTN expression correlates with infiltration of CD11b+/CD163+ TAMs and poor prognosis of GBM patients. Co-implantation of M2-like macrophages (MLCs) promoted GSC-driven tumour growth, but silencing PTN expression in MLCs mitigated their pro-tumorigenic activity. The PTN receptor PTPRZ1 is preferentially expressed in GSCs and also predicts GBM poor prognosis. Disrupting PTPRZ1 abrogated GSC maintenance and tumorigenic potential. Moreover, blocking the PTN-PTPRZ1 signalling by shRNA or anti-PTPRZ1 antibody potently suppressed GBM tumour growth and prolonged animal survival. Our study uncovered a critical molecular crosstalk between TAMs and GSCs through the PTN-PTPRZ1 paracrine signalling to support GBM malignant growth, indicating that targeting this signalling axis may have therapeutic potential.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。